Strategic Planning: Why Outside Counsel is Crucial for Your Business
Philip Crowley
April 4, 2023
Why Entrepreneurs Should Rely on a Trusted Advisor to Forecast What Lies Ahead Founders of startups and leaders of young
Why Entrepreneurs Should Rely on a Trusted Advisor to Forecast What Lies Ahead Founders of startups and leaders of young
Valuation of life sciences companies has been battered and the IPO window has closed, for now. But there are still
Last week I had the opportunity to attend the BioMedical Engineering Day at Stevens Institute of Technology in Hoboken, New Jersey. It
Don’t Let Common Equity Pitfalls Derail Your Startup Keeping to the fundamentals can be tough. As an overtasked and overwhelmed
Last month, the Consultants’ Network of Northern New Jersey, part of the IEEE North Jersey Section, hosted a virtual meeting called “The
Crowley Law LLC is thrilled to announce that Founder and Managing Partner, Philip P. Crowley has been appointed to the Board of Ben
Why Standard NDAs Aren’t Always Enough to Protect You A nondisclosure agreement, also called a confidentiality agreement, is a contract
Time and money. Innovative business ventures are often short on both. So, in the face of competing priorities, it can
Global Cyber Threats Are Now Targeting Medical Devices A hostile, controlling government launches a coordinated ransomware attack on computers across
The FDA regulatory gauntlet can be a daunting challenge. That’s especially true for startups new to the field. But it
Are you overlooking areas of risk that may be lurking in the contracts you have entered into? Below are 6
Drug sponsors face a long and winding path to take a drug from discovery to market. The Investigational New Drug
Patents For Humanity Program Improvement Act The Patents for Humanity Program Improvement Act, H.R. 7259, was introduced on June 18th,
According to the National Institutes of Health (NIH), there are over 7,000 diseases classified as rare, affecting an estimated 25-30 million Americans.
Recently Phil Crowley was asked by Marianne Kolbasuk McGee, the Executive Editor of the Information Security Media Group (ISMG) to weigh in on
How the FDA is streamlining it’s approval process for new therapies The FDA (Food and Drug Administration) is the regulatory arm of
The Securities and Exchange Commission recently announced a rule change to expand the definition of “accredited investor” ultimately allowing more
The COVID-19 pandemic has disrupted just about every national and global industry, and drug companies are certainly no exception.One of
Robots Are Going to Eliminate These Jobs Held by Humans… More >
No business wants unexpected liabilities. People across the country are returning to work in high-contact and other industries. It’s not
Healthcare provider organizations, pharmaceutical companies and medical device manufacturers all must take critical security… More >
The after-effects of the pandemic will be multi-faceted and far-reaching. In Parts One and Two of this discussion, I analyzed
Make no mistake – the Coronavirus pandemic is a serious matter. There is no doubt we will see the ripple
Crowley Law LLC is proud to support Hope Through Education and their mission is to help thousands of underprivileged students reach their full potential through the gift of a great education. Learn more about this organization.
